DrugPatentWatch Database Preview
Drugs in Development Information for TAK-228
Try a free trial
See Plans and Pricing
Summary for TAK-228
| US Patents | 28 |
| International Patents | 245 |
| US Patent Applications | 91 |
| WIPO Patent Applications | 48 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2018-01-01) |
| Vendors | 55 |
US Patents for TAK-228
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| TAK-228 | ➤ Sign Up | Low, immune enhancing, dose mtor inhibitors and uses thereof | Novartis AG (Basel, CH) | ➤ Sign Up |
| TAK-228 | ➤ Sign Up | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | ZHEJIANG DTRM BIOPHARMA CO. LTD. (Hangzhou, CN) | ➤ Sign Up |
| TAK-228 | ➤ Sign Up | Combination pharmaceutical compositions and uses thereof | INTELLIKINE LLC (La Jolla, CA) | ➤ Sign Up |
| TAK-228 | ➤ Sign Up | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Novartis AG (Basel, CH) The Trustees of the University of Pennsylvania (Philadelphia, PA) | ➤ Sign Up |
| TAK-228 | ➤ Sign Up | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Novartis AG (Basel, CH) The Trustees of the University of Pennsylvania (Philadelphia, PA) | ➤ Sign Up |
| TAK-228 | ➤ Sign Up | ULK1 inhibitors and methods using same | SALK INSTITUTE FOR BIOLOGICAL STUDIES (La Jolla, CA) SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA) YALE UNIVERSITY (New Haven, CT) | ➤ Sign Up |
| TAK-228 | ➤ Sign Up | Low, immune enhancing, dose MTOR inhibitors and uses thereof | Novartis AG (Basel, CH) | ➤ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TAK-228
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TAK-228 | Australia | 2014348657 | 2033-11-13 | ➤ Sign Up |
| TAK-228 | Australia | 2017245411 | 2033-11-13 | ➤ Sign Up |
| TAK-228 | Canada | 2929181 | 2033-11-13 | ➤ Sign Up |
| TAK-228 | China | 105899232 | 2033-11-13 | ➤ Sign Up |
| TAK-228 | Eurasian Patent Organization | 201690987 | 2033-11-13 | ➤ Sign Up |
| TAK-228 | European Patent Office | 3068435 | 2033-11-13 | ➤ Sign Up |
| TAK-228 | Japan | 2016537345 | 2033-11-13 | ➤ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
